Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.2.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.5.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAZEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.237EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBNEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.356EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.462EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.147EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.6 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.5 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.4 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.420EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.39.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.233EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.320EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.635EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.19 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.15 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.113EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.423EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.98.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.34.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.124.1.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.203EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used